You have 9 free searches left this month | for more free features.

Prophylactic Anticoagulation

Showing 1 - 25 of 2,832

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)

Not yet recruiting
  • Anticoagulants; Increased
  • catheter induced thromboprophylaxis
  • (no location specified)
Jan 21, 2023

Severe COVID-19 Pneumonia Trial in Créteil (Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose

Completed
  • Severe COVID-19 Pneumonia
  • Tinzaparin, Low dose prophylactic anticoagulation
  • +2 more
  • Créteil, France
    Henri Mondor Hospital
Sep 5, 2022

Covid19 Trial in Tehran (intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/

Completed
  • Covid19
  • intermediate dose Enoxaparin/ unfractionated heparin
  • +3 more
  • Tehran, Iran, Islamic Republic of
    Masih Daneshvari Hospital
Aug 14, 2021

Venous Thrombosis Trial in Shanghai (Rivaroxaban)

Recruiting
  • Venous Thrombosis
  • Shanghai, China
  • +3 more
Feb 10, 2022

Covid19, Thrombosis Trial in Spain (Tinzaparin)

Completed
  • Covid19
  • Thrombosis
  • A Coruña, Spain
  • +17 more
Sep 13, 2022

Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)

Terminated
  • COVID-19
  • Enoxaparin Higher Dose
  • Lower-dose prophylactic anticoagulation
  • New York, New York
    NYU Langone Health
Oct 5, 2020

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19

Completed
  • Covid19
    • Royal Oak, Michigan
      Beaumont Health System (BHS)
    Apr 1, 2021

    Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)

    Completed
    • Sars-CoV2
    • COVID
    • Newark, New Jersey
    • +5 more
    Nov 17, 2021

    Covid19 Trial in Banha (Ivermectin, Hydroxychloroquine, personal protective Measures)

    Completed
    • Covid19
    • Banhā, Qaluopia, Egypt
      Benha Faculty of Medicine, Benha University
    Dec 11, 2020

    Venous Thrombosis Due to Central Venous Access Device (Disorder), Prophylactic Anticoagulation, Patients With Tumor Trial in

    Unknown status
    • Venous Thrombosis Due to Central Venous Access Device (Disorder)
    • +2 more
    • Rivaroxaban 10mg
    • +2 more
    • Dongyang, Zhejiang, China
    • +27 more
    Jun 26, 2020

    COVID 19 Associated Coagulopathy Trial in Iowa City, La Crosse (Intermediate dose thromboprophylaxis, Standard of Care

    Recruiting
    • COVID 19 Associated Coagulopathy
    • Intermediate dose thromboprophylaxis
    • Standard of Care thromboprophylaxis
    • Iowa City, Iowa
    • +1 more
    Jun 18, 2020

    Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose

    Recruiting
    • Venous Thromboembolism
    • Prophylactic low molecular weight heparin
    • Low molecular weight heparin and low-dose aspirin
    • Toronto, Ontario, Canada
      Mount Sinai Hospital
    Jan 18, 2023

    Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or

    Recruiting
    • Covid19
    • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
    • Low dose Low molecular weight heparin or Placebo
    • Aachen, Germany
    • +9 more
    May 16, 2022

    Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia Trial in Dijon (treatment "intervention",

    Recruiting
    • Prolonged Anticoagulation
    • +2 more
    • treatment "intervention"
    • +2 more
    • Dijon, France
      Chu Dijon Bourgogne
    Jul 4, 2022

    COVID, Sars-CoV2 Trial in Switzerland (Enoxaparin)

    Terminated
    • COVID
    • Sars-CoV2
    • Geneva, Switzerland
    • +3 more
    Sep 7, 2021

    Coronavirus Infection Trial in Brazil (Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,

    Completed
    • Coronavirus Infection
    • Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed
    • Group 2: control group with enoxaparin 40mg/d
    • Salvador, Bahia, Brazil
    • +35 more
    Jun 8, 2021

    STEMI - ST Elevation Myocardial Infarction Trial in Zunyi (NOAC+DAPT, DAPT)

    Recruiting
    • STEMI - ST Elevation Myocardial Infarction
    • Zunyi, Guizhou, China
      Affiliated Hospital of Zunyi Medical University
    Aug 25, 2023

    Reduce Postoperative Atrial Fibrillation After Cardiac Surgery

    Active, not recruiting
    • Atrial Fibrillation New Onset
    • Prophylactic amiodarone and posterior pericardiotomy
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 20, 2023

    Thrombophilia Trial in Boston (No intervention)

    Active, not recruiting
    • Thrombophilia
    • No intervention
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 11, 2023

    COVID-19 Trial in Germany (Rivaroxaban, Standard Of Care (SOC))

    Terminated
    • COVID-19
    • Freiburg, Baden-Württemberg, Germany
    • +23 more
    Dec 23, 2021

    Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism Trial in Nashville (Low intensity

    Recruiting
    • Acute Hypoxemic Respiratory Failure
    • +2 more
    • Low intensity anticoagulation
    • Moderate Intensity Anticoagulation
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    May 15, 2022

    COVID-19, SARS-CoV-2 Trial in Worldwide (Enoxaparin, Apixaban)

    Recruiting
    • COVID-19
    • SARS-CoV-2
    • New York, New York
    • +20 more
    Jan 18, 2022

    Peripartum Cardiomyopathy, Postpartum Trial in Pittsburgh (Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart

    Recruiting
    • Peripartum Cardiomyopathy, Postpartum
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Jun 9, 2022

    Blood Clots and Bleeding in Hematological Malignancies, HAT

    Recruiting
    • Acute Leukemia
    • +7 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jun 17, 2022